Literature DB >> 34039484

Management of the major complications of cirrhosis: Beyond guidelines.

Juan Carlos Garcia-Pagan1, Claire Francoz2, Sara Montagnese3, Marco Senzolo4, Rajeshwar P Mookerjee5.   

Abstract

Along with a growing understanding of the pathophysiology of cirrhosis and its complications, new therapies and management strategies have emerged in recent years. Many of these advances have helped inform the current EASL clinical practice guidelines1 on the management of some of the key complications of cirrhosis, such as ascites, variceal bleeding and infection. However, there are still some aspects of management where the evidence base is less clear, and/or where opinions amongst practitioners remain divided. Some of these more controversial areas are explored in this section, wherein we present evidence culminating in a suggested management approach based on expert opinion and extending beyond the current guidelines.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cirrhosis; Controversies; Decompensation; Guidelines; Management

Mesh:

Year:  2021        PMID: 34039484     DOI: 10.1016/j.jhep.2021.01.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  New concepts and perspectives in decompensated cirrhosis.

Authors:  Rajiv Jalan; Gyongyi Szabo
Journal:  J Hepatol       Date:  2021-07       Impact factor: 30.083

2.  Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)-a single center, open-label, three-arm, randomized, controlled intervention trial.

Authors:  Asieb Sekandarzad; Enya Weber; Eric Peter Prager; Erika Graf; Dominik Bettinger; Tobias Wengenmayer; Alexander Supady
Journal:  Trials       Date:  2022-03-18       Impact factor: 2.279

3.  Influence of Metabolic Risk Factors on the Risk of Bacterial Infections in Hepatitis B-Related Cirrhosis: A 10-Year Cohort Study.

Authors:  Qiao Yang; Yifan Tong; Borui Pi; Hong Yu; Fangfang Lv
Journal:  Front Med (Lausanne)       Date:  2022-04-14

4.  Associations Between Endoscopic Primary Prophylaxis and Rebleeding in Liver Cirrhosis Patients with Esophagogastric Variceal Bleeding.

Authors:  Yanying Gao; Haixia Yuan; Tao Han; Xu Zhang; Fenghui Li; Fei Tang; Hua Liu
Journal:  Front Surg       Date:  2022-07-12

5.  Iohexol plasma and urinary concentrations in cirrhotic patients: A pilot study.

Authors:  Paul Carrier; Alexandre Destere; Baptiste Giguet; Marilyne Debette-Gratien; Marie Essig; Caroline Monchaud; Jean-Baptiste Woillard; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2022-08-27

Review 6.  Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges.

Authors:  Tian-Tian Li; Ze-Rui Wang; Wei-Qi Yao; En-Qiang Linghu; Fu-Sheng Wang; Lei Shi
Journal:  Stem Cells Transl Med       Date:  2022-09-21       Impact factor: 7.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.